Zutex-T 250mg/31.25mg Injection
Marketer
Zodak Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Zutex-T 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, consistent adherence to the prescribed dosage is crucial; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical assistance. Prior to commencing treatment, inform your physician of all concurrent medications and pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration facilitate recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Zutex-T 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Zutex-T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Zutex-T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Zutex-T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Zutex-T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Zutex-T 250mg/31.25mg Injection works:
The injectable formulation Zutex-T (250mg/31.25mg) combines ceftriaxone, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. This synergistic action combats bacterial infection by both directly hindering bacterial growth and overcoming bacterial resistance mechanisms that would otherwise inactivate the ceftriaxone.
SAFETY ADVICE
AlcoholSAFE
Zutex-T 250mg/31.25mg Injection does not produce adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Zutex-T (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Zutex-T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Zutex-T 250mg/31.25mg Injection could reduce awareness, impair visual acuity, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zutex-T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Zutex-T 250mg/31.25mg Injection cautiously, potentially requiring a modified dosage. Medical advice is recommended. Dosage alteration of Zutex-T 250mg/31.25mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Zutex-T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Zutex-T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Zutex-T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently